These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22132829)

  • 1. Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
    Koloszar S; Pal Z; Kereszturi A; Vajda G; Pal A; Daru J
    Climacteric; 2012 Feb; 15(1):93-4. PubMed ID: 22132829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
    Stilwill SE; Cooper BC
    J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding.
    Heller DS; Mosquera C; Goldsmith LT; Cracchiolo B
    J Reprod Med; 2011; 56(3-4):110-2. PubMed ID: 21542526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
    Agorastos T; Vaitsi V; Pantazis K; Efstathiadis E; Vavilis D; Bontis JN
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):239-40. PubMed ID: 15653211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal uterine bleeding of nonorganic cause.
    Choo YC; Mak KC; Hsu C; Wong TS; Ma HK
    Obstet Gynecol; 1985 Aug; 66(2):225-8. PubMed ID: 4022485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata.
    Kaunitz AM
    Menopause; 2007; 14(5):941-3. PubMed ID: 17667148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy.
    Feldman S; Shapter A; Welch WR; Berkowitz RS
    Gynecol Oncol; 1994 Oct; 55(1):56-9. PubMed ID: 7959267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of endometrial hyperplasia in women with abnormal uterine bleeding.
    Loverro G; Bettocchi S; Vicino M; Selvaggi L
    Acta Eur Fertil; 1994; 25(1):23-5. PubMed ID: 7887077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term transdermal estradiol therapy: effects on endometrial histology and bleeding patterns.
    Clisham PR; Cedars MI; Greendale G; Fu YS; Gambone J; Judd HL
    Obstet Gynecol; 1992 Feb; 79(2):196-201. PubMed ID: 1731285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole as primary therapy for endometrial hyperplasia in young women.
    Li HZ; Chen XN; Qiao J
    Int J Gynaecol Obstet; 2008 Jan; 100(1):10-2. PubMed ID: 17889878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of premenopausal endometrial hyperplasia by a combination of a long-acting estrogen and a cyclic progestogen.
    Ricciardi I; Bertorello G; Bruni G; Cali A; Imparato E; Sallusto A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):402-16. PubMed ID: 4198302
    [No Abstract]   [Full Text] [Related]  

  • 14. Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
    Burnett AF; Bahador A; Amezcua C
    Gynecol Oncol; 2004 Sep; 94(3):832-4. PubMed ID: 15350383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice.
    Lara AC; Cândido EB; Vidigal PV; Rocha AL; Carvalho-Macedo AC; Carneiro MM; Silva-Filho AL
    Acta Cir Bras; 2016 Apr; 31(4):286-93. PubMed ID: 27168542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrasonographic evaluation of the endometrium in postmenopausal women to select the high risk group of endometrial carcinoma of the uterus].
    Kawabata M; Tsuda H; Kawabata K; Umesaki N; Yamagata S; Sugawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1512-6. PubMed ID: 2685138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term endometrial and breast safety of a specific, standardized soy extract.
    Palacios S; Pornel B; Vázquez F; Aubert L; Chantre P; Marès P
    Climacteric; 2010 Aug; 13(4):368-75. PubMed ID: 20380569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
    Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
    Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
    Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological findings in 226 women with post-menopausal uterine bleeding.
    Lidor A; Ismajovich B; Confino E; David MP
    Acta Obstet Gynecol Scand; 1986; 65(1):41-3. PubMed ID: 3716779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.